Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Silverchair Information Systems full text link Silverchair Information Systems Free PMC article
Full text links

Actions

Share

.2009 Apr;21(4):361-77.
doi: 10.1093/intimm/dxp003. Epub 2009 Feb 3.

GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity

Affiliations

GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity

Aya Yokota et al. Int Immunol.2009 Apr.

Abstract

Retinoic acid (RA) produced by intestinal dendritic cells (DCs) imprints gut-homing specificity on lymphocytes and enhances Foxp3(+) regulatory T-cell differentiation. The expression of aldehyde dehydrogenase (ALDH) 1A in these DCs is essential for the RA production. However, it remains unclear how the steady-state ALDH1A expression is induced under specific pathogen-free (SPF) conditions. Here, we found that bone marrow-derived dendritic cells (BM-DCs) generated with granulocyte-macrophage colony-stimulating factor (GM-CSF) expressed Aldh1a2, an isoform of Aldh1a, but that fms-related tyrosine kinase 3 ligand-generated BM-DCs did not. DCs from mesenteric lymph nodes (MLN) and Peyer's patches (PP) of normal SPF mice expressed ALDH1A2, but not the other known RA-producing enzymes. Employing a flow cytometric method, we detected ALDH activities in 10-30% of PP-DCs and MLN-DCs. They were CD11c(high)CD4(-/low)CD8alpha(intermediate)CD11b(-/low) F4/80(low/intermediate)CD45RB(low)CD86(high)MHC class II(high)B220(-)CD103(+). Equivalent levels of aldehyde dehydrogenase activity (ALDHact) and ALDH1A2 expression were induced synergistically by GM-CSF and IL-4 in splenic DCs in vitro. In BM-DCs, however, additional signals via Toll-like receptors or RA receptors were required for inducing the equivalent levels. The generated ALDH1A2(+) DCs triggered T cells to express gut-homing receptors or Foxp3. GM-CSF receptor-deficient or vitamin A-deficient mice exhibited marked reductions in the ALDHact in intestinal DCs and the T cell number in the intestinal lamina propria, whereas IL-4 receptor-mediated signals were dispensable. GM-CSF(+)CD11c(-)F4/80(+) cells existed constitutively in the intestinal tissues. The results suggest that GM-CSF and RA itself are pivotal among multiple microenvironment factors that enable intestinal DCs to produce RA.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
MLN-DCs and PP-DCs expressAldh1a2 and possess ALDHact. (A) Expression of ALDH1A2 in CD11c or CD11c+ cells from MLN or SPL of B10.D2 mice was analyzed by immunoblotting. Data are representative of two independent experiments. (B) Expression ofAldh1a1,Aldh1a2,Aldh1a3,Aldh8a1,Cyp1b1,Cyp2j6 andRplp0 as a loading control in CD11c or CD11c+ cells from MLN, PP or SPL was analyzed by RT-PCR. Data are representative of two independent experiments. (C) Expression ofAldh1a2 in CD103+ or CD103 DCs from MLN or PP was analyzed by quantitative real-time PCR. Data are presented as mean ± SEM and are representative of three independent experiments. Statistical significance was determined by the one-way analysis of variance; ***P < 0.001. (D) Cells from MLN or PP were incubated with ALDEFLUOR, co-stained for CD11c and CD3ε, CD19, CD49b, F4/80 or Gr-1 and analyzed by flow cytometry. Pre-gated CD11c cells are shown in the dot plots except those for CD11c staining. Data are representative of two independent experiments. (E) MLN-DCs, PP-DCs or SPL-DCs were incubated with ALDEFLUOR in the presence (bottom) or absence (top) of the ALDH inhibitor DEAB and stained for CD11c expression. Numbers adjacent to gates indicate percentage of ALDHacthigh cells (upper number) or ALDHactintermediate cells (lower number). Data are representative of three independent experiments. (F) ALDEFLUOR-treated MLN-DCs were co-stained for CD11c and B220, CD4, CD8α, CD11b, CD45RB, CD86, F4/80, MHC class II or CD103 expression. ALDHacthigh and ALDHact−/intermediate cells are shown as red and blue dots, respectively. Data are representative of two independent experiments.
Fig. 2.
Fig. 2.
GM-CSF and IL-4 synergistically induce ALDH1A2 expression in DCs. (A) Expression ofAldh1a2 in GM-CSF-induced or Flt3L-induced BM-DCs was analyzed by quantitative real-time PCR. Data are presented as mean ± SEM and are representative of three independent experiments. Statistical significance was determined by the Student'st test; ***P < 0.001. (B) Expression ofAldh1a2 in Flt3L-induced BM-DCs (left) and SPL-DCs (right) cultured with graded concentrations of GM-CSF was analyzed by quantitative real-time PCR. Data are presented as mean ± SEM and are representative of three independent experiments. Statistical significance was determined by the one-way analysis of variance (ANOVA). ***P < 0.001 versus untreated. (C) Flt3L-induced BM-DCs were cultured with IL-3 (10 ng ml−1), IL-4 (10 ng ml−1), IL-5 (10 ng ml−1), IL-6 (10 ng ml−1), IL-10 (10 ng ml−1), IL-12 (10 ng ml−1), IL-13 (10 ng ml−1), IFN-α (104 U ml−1), IFN-β (104 U ml−1), IFN-γ (10 ng ml−1), TNF-α (10 ng ml−1), TGF-β1 (10 ng ml−1), TGF-β2 (10 ng ml−1), TSLP (10 ng ml−1), CX3CL1 (10 ng ml−1), prostaglandin E2 (PGE2; 10−6 M) or leukotrien B4 (LTB4; 10−7 M). The expression ofAldh1a2 was assessed by semi-quantitative real-time PCR. The mRNA expression of treated cells is expressed as the ‘fold induction’ relative to that of untreated cells. Data are presented as mean ± SEM and are representative of two independent experiments. (D–F) Flt3L-induced BM-DCs (left) or SPL-DCs (right) were cultured with medium alone (none), GM-CSF (10 ng ml−1), IL-4 (10 ng ml−1) or GM-CSF and IL-4 (10 ng ml−1 each). (D) Expression ofAldh1a2 was analyzed by quantitative real-time PCR. Data are presented as mean ± SEM and are representative of more than three independent experiments. Statistical significance was determined by the one-way ANOVA. ***P < 0.001 versus all samples. (E) The cultured DCs were incubated with ALDEFLUOR in the presence (solid lines) or absence (shaded histograms) of DEAB and were analyzed by flow cytometry. Numbers in histogram plots indicate percentage of ALDHact+ cells. Data are representative of more than three independent experiments. (F) Expression of ALDH1A2 in DCs cultured with GM-CSF and IL-4 was analyzed by immunoblotting. Numbers below immunoblot indicate the signal intensity of treated DCs. Data are representative of two independent experiments.
Fig. 3.
Fig. 3.
TLR-mediated maturation signals enhanceAldh1a2 expression and ALDHact in BM-DCs. Flt3L-induced BM-DCs (A–C) or SPL-DCs (D and E) were cultured with medium alone (none), sPGN (10 μg ml−1), poly(I:C) (1 μg ml−1), LPS (1 μg ml−1), R837 (1 μg ml−1) or CpG ODN 1826 (CpG; 1 μM) in the presence or absence of GM-CSF and/or IL-4 (10 ng ml−1 each). (A and D) Expression ofAldh1a2 was assessed by semi-quantitative real-time PCR. The mRNA expression of treated cells is expressed as the ‘fold induction’ relative to that of untreated cells (cultured with medium alone without GM-CSF or IL-4). (B and E) DCs were cultured with medium alone or LPS in the presence or absence of GM-CSF and IL-4, incubated with ALDEFLUOR and co-stained for CD11c and CD86 expression. (C) BM-DCs were cultured with LPS, GM-CSF and IL-4, incubated with ALDEFLUOR and co-stained for CD11c and B220, CD4, CD8α, CD11b, CD45RB, CD80, CD103, F4/80 or MHC class II expression. ALDHact+ cells are shown as red dots. All data are representative of two independent experiments.
Fig. 4.
Fig. 4.
DCs treated with GM-CSF or IL-4 and/or LPS induce the expression of gut-homing receptors on CD4+ T cells. Flt3L-induced BM-DCs were treated with medium alone (none), GM-CSF (10 ng ml−1), IL-4 (10 ng ml−1) or GM-CSF and IL-4 (10 ng ml−1 each). To promote full maturation of BM-DCs, LPS (1 μg ml−1) was added to their cultures. The treated DCs were pulsed with OVA peptide P323-339 (1 μM) and co-cultured with naive DO11.10 CD4+ T cells at a ratio of 1:5 in the presence or absence of DEAB (100 μM). On day 5 of culture, cells were stained for CCR9 (top), α4β7 (middle) and E-selectin ligands (bottom) and analyzed by flow cytometry. (A) The expression levels are presented as ΔMFI. Data are presented as mean ± SEM and are representative of more than three independent experiments. Statistical significance was determined by the one-way analysis of variance; ***P < 0.001. (B) Histogram plots of each staining of T cells co-cultured with untreated or GM-CSF + IL-4-treated DCs are shown. Shaded histograms and solid lines indicate specific staining and isotype control, respectively. Numbers in histogram plots indicate ΔMFI.
Fig. 5.
Fig. 5.
DCs treated with GM-CSF and/or IL-4 enhance the differentiation of Foxp3+ T cells, but suppress the differentiation of Th17 cells. (A and B) SPL-DCs were treated with medium alone (none), GM-CSF (10 ng ml−1), IL-4 (10 ng ml−1) or GM-CSF and IL-4 (10 ng ml−1 each) and co-cultured with naive DO11.10 CD4+ T cells at a ratio of 1:10 in the presence of OVA peptide P323-339 (1 μM) and IL-2 (100 U ml−1) with or without TGF-β1 (5 ng ml−1). DEAB (100 μM) was added to some culture wells. On day 5 of culture, cells were stained for intracellular Foxp3 and analyzed by flow cytometry. (A) The graph shows the mean ± SEM of percentage of Foxp3+ T cells generated in each culture condition. (B) Histogram plots of T cells co-cultured with untreated or GM-CSF + IL-4-treated DCs are shown. Shaded histograms and solid lines indicate specific staining and isotype control, respectively. The number shown in each panel indicates the percentage of Foxp3+ cells. (C and D) The treated DCs were co-cultured with naive DO11.10 CD4+ T cells as described in (A and B), but IL-6 and IL-23 (20 ng ml−1 each) were also included in the culture. On day 5 of culture, cells were re-stimulated for 5 h with phorbol 12-myristate 13-acetate and ionomycin and stained for intracellular IL-17 and IFN-γ. (C) The graph shows the mean ± SEM of percentage of IL-17+IFN-γ cells generated in each culture condition. (D) Dot plots of T cells co-cultured with untreated or GM-CSF + IL-4-treated DCs are shown. The number shown in each panel indicates the percentage of IL-17+IFN-γ cells. All data are representative of two independent experiments. Statistical significance was determined by the one-way analysis of variance; ***P < 0.001.
Fig. 6.
Fig. 6.
GM-CSF receptor-mediated signals are critical for MLN-DCs to acquire ALDHact and the capacity to imprint gut-homing specificity on T cells. (A) Cells from MLN, PP or SPL of wt or Beta-c−/− mice were incubated with ALDEFLUOR and stained for CD11c expression. Values indicate ΔMFI of ALDEFLUOR in CD11c+ cells. Data are presented as mean ± SEM (four mice in each genotype). Statistical significance was determined by the Student'st test. ***P < 0.001 versus wt mice. (B) MLN-DCs were isolated from Beta-c−/− or wt mice and co-cultured with naive CD4+ T cells from wt mice at a ratio of 1:5 in the presence of soluble anti-CD3ε mAb (1 μg ml−1). DEAB (100 μM) was added to some wells. On day 5 of culture, the expression levels of CCR9 (left) and α4β7 (right) on T cells were analyzed by flow cytometry. Data are presented as mean ± SEM and are representative of two independent experiments. Statistical significance was determined by the one-way analysis of variance; ***P < 0.001. (C–E) Immunohistochemical analysis was performed on CD4+ cells or CD8+ cells in PP, villi of small intestine, liver or lung from wt or Beta-c−/− mice. Frozen sections were stained for CD4 (C and E, red) or CD8 (D, red). Cell nuclei were visualized with TO-PRO-3 (blue). Data are representative of two independent experiments. Scale bars, 200 μm (PP); 50 μm (villi, liver and lung). (F) Cells from PP, MLN or SPL of wt or Beta-c−/− mice were stained for B220 and IgA. The graph shows the mean ± SEM (four mice in each genotype) of percentage of IgA+ cells in B220+ cells. Statistical significance was determined by the Student'st test. **P < 0.01 versus wt mice. Dot plots of pre-gated B220+ cells from PP are shown. Numbers adjacent to gates indicate percentage of IgA+ cells.
Fig. 7.
Fig. 7.
GM-CSF+CD11cF4/80+ cells constitutively exist in MLN, PP and the intestinal LP. (A) IECs were isolated from the jejunum and ileum of B10.D2 mice. CD11cF4/80+ cells were isolated from SPL, PLN and MLN of the same mice. The mRNA expression ofCsf2 was assessed by quantitative real-time PCR. Data are presented as mean ± SEM and are representative of two independent experiments. (B) Frozen sections of MLN, PP or the intestinal LP were co-stained for GM-CSF (red) and CD11c (left, green) or F4/80 (right, green). (C) Frozen sections of MLN or PLN (brachial LN) were stained for GM-CSF (red) and F4/80 (green). Cell nuclei were visualized with TO-PRO-3 (blue). Data are representative of two independent experiments. Scale bars, 50 μm.
Fig. 8.
Fig. 8.
Vitamin A is essential for GM-CSF-inducedAldh1a2 expression in DCs andCsf2 expression in CD11cF4/80+ cells in MLN. (A) Expression ofAldh1a2 in MLN-DCs from control or vitamin A-deficient (ΔVit.A) mice was analyzed by quantitative real-time PCR. Data are presented as mean ± SEM and are representative of two independent experiments. Statistical significance was determined by the Student'st test; ***P < 0.001. (B) Cells from MLN of control or vitamin A-deficient mice were incubated with ALDEFLUOR and stained for CD11c expression. Values indicate ΔMFI of ALDEFLUOR in CD11c+ cells. Data are presented as mean ± SEM (four mice in each group). Statistical significance was determined by the Student'st test; ***P < 0.001. (C) Expression ofAldh1a2 in Flt3L-induced BM-DCs (left) or SPL-DCs (right) cultured with medium alone (none), all-trans-RA (1 μM) or GM-CSF (10 ng ml−1) was analyzed by quantitative real-time PCR. Data are presented as mean ± SEM and are representative of two independent experiments. Statistical significance was determined by the one-way analysis of variance (ANOVA); ***P < 0.001. (D) Expression ofAldh1a2 expression in Flt3L-induced BM-DCs (left) or SPL-DCs (right) cultured with GM-CSF (10 ng ml−1) in the presence or absence of LE540 (1 μM) was analyzed by quantitative real-time PCR. Data are presented as mean ± SEM and are representative of two independent experiments. Statistical significance was determined by the one-way ANOVA; ***P < 0.001. (E) Expression ofCsf2 in CD11c+, CD11cF4/80+ or CD11cF4/80 cells from MLN of control or vitamin A-deficient mice was analyzed by quantitative real-time PCR. Data are presented as mean ± SEM and are representative of two independent experiments. Statistical significance was determined by the one-way ANOVA. ***P < 0.001 versus control mice.
Fig. 9.
Fig. 9.
Proposed model for the mechanism of GM-CSF-mediated induction of RA-producing DCs in the intestinal tissues. GM-CSF plays a critical role to induce the ALDH1A2 expression in DCs. In the intestinal tissues, CD11cF4/80+ cells (i.e. macrophages or granulocytes) produce GM-CSF, which induces the ALDH1A2 expression in DCs. DC maturation signals induced by intestinal stimuli including TLR ligands from intestinal bacterial flora enhance the ALDH1A2 expression. The ALDH1A2+ DCs produce RA and imprint gut-homing specificity on T cells upon antigenic stimulation. These DCs also promote the differentiation of naive T cells to Foxp3+ Treg cells in the presence of TGF-β. RA is required not only for the GM-CSF-induced expression of ALDH1A2 in DCs but also for the GM-CSF production by CD11cF4/80+ cells or their proper migration. Thus, ALDH1A2+ DCs as well as ALDH1A1+ IECs may provide RA to DCs and CD11cF4/80+ cells and enhance the positive feedback loop for RA production in the intestine.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity. 2004;21:527. - PubMed
    1. Mora JR, Iwata M, Eksteen B, et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science. 2006;314:1157. - PubMed
    1. Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317:256. - PubMed
    1. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 2007;204:1757. - PMC - PubMed
    1. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 2007;204:1765. - PMC - PubMed

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full text links
Silverchair Information Systems full text link Silverchair Information Systems Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp